English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community

Regulatory

+ Regulatory
Jamie Barrand | Dec 29, 2015

Lawmakers express alarm over Medicaid exchange eligibility determinations

+ Technology/Innovation
Jamie Barrand | Dec 29, 2015

Studies of healthy habits included among AHA's top research advances of 2015

+ Regulatory
Jamie Barrand | Dec 29, 2015

2016 budget bill includes increases for mental health initiatives

+ Regulatory
Jamie Barrand | Dec 29, 2015

Upton calls for broader review of concussions

+ Technology/Innovation
Jamie Barrand | Dec 29, 2015

Omnibus spending bill includes funding for rare disease research

+ Technology/Innovation
Jamie Barrand | Dec 29, 2015

Adcertis launches phase 1/2 trial for lymphoma therapy

+ Regulatory
Jamie Barrand | Dec 29, 2015

CMS issues final rule on prior authorization process for durable medical equipment

+ Technology/Innovation
Jamie Barrand | Dec 29, 2015

FDA grants Breakthrough Therapy Designation to Boehringer Ingelheim's new lung cancer therapy

Trending

+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update

+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate

+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'

+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes

  • « First
  • «
  • …
  • 481
  • 482
  • 483
  • 484
  • 485
  • 486
  • 487
  • …
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2026 Patient Daily